GLUE Covered Call Strategy
GLUE (Monte Rosa Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, and breast cancers; NEK7 for the treatment of inflammatory diseases, such as Crohn's disease, neurodegenerative disease, diabetes, and liver disease; VAV1, a target protein for autoimmune diseases; and BCL11A, a therapeutically-relevant protein in hemoglobinopathies. Monte Rosa Therapeutics, Inc. was incorporated in 2019 and is headquartered in Boston, Massachusetts.
GLUE (Monte Rosa Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.23B, a beta of 1.62 versus the broader market, a 52-week range of 3.51-25.77, average daily share volume of 1.0M, a public-listing history dating back to 2021, approximately 142 full-time employees. These structural characteristics shape how GLUE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.62 indicates GLUE has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a covered call on GLUE?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current GLUE snapshot
As of May 15, 2026, spot at $18.13, ATM IV 106.10%, IV rank 43.63%, expected move 30.42%. The covered call on GLUE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this covered call structure on GLUE specifically: GLUE IV at 106.10% is mid-range versus its 1-year history, so the credit collected on a GLUE covered call sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 30.42% (roughly $5.51 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated GLUE expiries trade a higher absolute premium for lower per-day decay. Position sizing on GLUE should anchor to the underlying notional of $18.13 per share and to the trader's directional view on GLUE stock.
GLUE covered call setup
The GLUE covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With GLUE near $18.13, the first option leg uses a $19.04 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed GLUE chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 GLUE shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $18.13 | long |
| Sell 1 | Call | $19.04 | N/A |
GLUE covered call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
GLUE covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on GLUE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use covered call on GLUE
Covered calls on GLUE are an income strategy run on existing GLUE stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
GLUE thesis for this covered call
The market-implied 1-standard-deviation range for GLUE extends from approximately $12.62 on the downside to $23.64 on the upside. A GLUE covered call collects premium on an existing long GLUE position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether GLUE will breach that level within the expiration window. Current GLUE IV rank near 43.63% is mid-range against its 1-year distribution, so the IV signal is neutral; the covered call thesis on GLUE should anchor more to the directional view and the expected-move geometry. As a Healthcare name, GLUE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to GLUE-specific events.
GLUE covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. GLUE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move GLUE alongside the broader basket even when GLUE-specific fundamentals are unchanged. Short-premium structures like a covered call on GLUE carry tail risk when realized volatility exceeds the implied move; review historical GLUE earnings reactions and macro stress periods before sizing. Always rebuild the position from current GLUE chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on GLUE?
- A covered call on GLUE is the covered call strategy applied to GLUE (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With GLUE stock trading near $18.13, the strikes shown on this page are snapped to the nearest listed GLUE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are GLUE covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the GLUE covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 106.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a GLUE covered call?
- The breakeven for the GLUE covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current GLUE market-implied 1-standard-deviation expected move is approximately 30.42%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on GLUE?
- Covered calls on GLUE are an income strategy run on existing GLUE stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current GLUE implied volatility affect this covered call?
- GLUE ATM IV is at 106.10% with IV rank near 43.63%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.